GB-102 (sunitinib malate depot formulation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GB-102 (sunitinib malate depot formulation), covering 2022-01-11 to 2022-01-11. Get the full timeline:
Most recent: Clinical Trial Update: A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD [Phase 2]